Acquisition Announced

Tempus AI acquisition of Personalis

US$1.9bn equity value

Announced 20 Jul 2026 · NASDAQ: PSNL · US$16.25 cash and scrip per share

Advisers

Tempus AI

Acquirer

Financial adviser
Legal adviser
Target
Personalis
Acquirer
Tempus AI
Target based in
United States
Buyer based in
United States
Sector
Diagnostics
Tags
Diagnostics, Oncology, Life Sciences

In the league tables

Similar deals

All diagnostics deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.